BlinkLab

North Shore Pediatric Therapy in Chicago Joins BlinkLab’s US Registrational Study

BlinkLab Limited (ASX:BB1) (“BlinkLab”, or the “Company”), an innovative digital healthcare company developing AI-powered smartphone technology to transform the autism and ADHD diagnostic markets, is pleased to announce that North Shore Pediatric Therapy (“NSPT”) is joining our US clinical study. NSPT is the second US-based site to on-board for the 100-patient initial phase of the registrational study. Enrolment from the NSPT-site is expected to commence in the coming weeks.


  • US-based North Shore Pediatric Therapy (“NSPT”) is the second clinical site to join BlinkLab’s registrational study.
  • Located in the Chicago area, NSPT is a recognized leader in early autism intervention services, specializing in Applied Behavior Analysis (ABA), neuropsychology, speech therapy, occupational therapy, and mental health support.
  • The NSPT clinical trial site is set to begin patient recruitment and diagnostic testing in the coming weeks, supporting timely and efficient data collection for the study.
  • Together, with PriMED Clinical Research, these two leading US-based autism centers provide access to a large pool of diverse subjects that will accelerate the recruitment process and ensure high-quality data collection.

NSPT was selected for this study due to its extensive expertise in administering the ADOS-2 diagnostic tool, which is widely recognized as the gold standard for autism diagnosis. Their experienced neuropsychology team specializes in conducting comprehensive, play-based assessments that evaluate social, emotional, and communication behaviors, ensuring precise and reliable autism diagnoses. As part of our US registrational study, NSPT’s use of the ADOS-2 will serve as a critical benchmark for standard-of-care comparisons, helping validate the effectiveness of our Blinklab Dx 1 test.

In addition to their clinical expertise, NSPT provides access to a diverse population of children throughout the Chicago area, which is an essential factor in ensuring the study reflects a broad range of backgrounds and developmental profiles. Their ability to recruit children as young as 18 months old is particularly valuable for the BlinkLab study, as our mission is to enable early diagnosis and improve long-term outcomes for children with autism. With a strong track record in early intervention and autism diagnostics, NSPT’s participation enhances the study’s robustness, credibility, and real-world applicability, ultimately contributing to the advancement of Blinklab’s more accurate and accessible autism screening tool.


Click here for the full ASX Release

This article includes content from Blinklab Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

BB1:AU
The Conversation (0)
BlinkLab Limited

BlinkLab Limited


Keep reading...Show less

Revolutionising Mental Health Care Through Mobile Solutions

Green NVIDIA logo in a glossy 3D style on a dark background.

NVIDIA Facing Weak Demand for New Chip as Chinese Firms Turn to Homegrown Silicon

NVIDIA's (NASDAQ:NVDA) new RTX6000D chip, built to comply with US export curbs, is seeing little demand from major Chinese firms, sources familiar with the matter told Reuters this week.

Tests showed it lags the banned RTX5090, which remains widely available through gray market channels at less than half the RTX6000D’s price of roughly 50,000 yuan (around US$7,000).

NVIDIA currently faces a balancing dilemma in China, where the US has barred exports of its most advanced processors to limit Beijing’s artificial intelligence (AI) progress, forcing the company to design downgraded models.

Keep reading...Show less
Syntheia (CSE:SYAI)

Syntheia Announces Closing of Private Placement

Syntheia Corp. (CSE: SYAI) (syntheia.ai) (the "Company"), is pleased to announce that further to its press releases dated July 23, 2025, and September 2, 2025 the Company has closed the second tranche of its non-brokered private placement financing for gross proceeds of $709,677.48 through the issuance of 5,913,979 units (each, a "Unit") at a price of $0.12 per Unit (the "Offering").

Each Unit was comprised of one common share in the capital of the Company (each, a "Common Share") and one Common Share purchase warrant (each, a "Warrant"). Each Warrant is exercisable to acquire one Common Share at a price of $0.16 until September 2, 2030 (the "Expiry Date"), subject to an accelerated expiry in the event the volume weighted average trading price of the Common Shares exceeds $0.20 for 20 consecutive trading days, the Company may, within 10 business days of the occurrence of such event, deliver a notice to the holders of the Warrants accelerating their Expiry Date to a date that is not less than 30 days following the date of such notice and the issuance of a press release by the Company announcing the acceleration notice (the "Accelerated Exercise Period"). Any unexercised Warrants shall automatically expire at the end of the Accelerated Exercise Period.

Keep reading...Show less
Circuit board forming a brain shape on a digital blue background.

Nebius Shares Soar on US$17.4 Billion Microsoft AI Deal

Nebius Group (NASDAQ:NBIS) surged on Tuesday (September 9) after announcing a multibillion-dollar deal with Microsoft (NASDAQ:MSFT) to provide dedicated artificial intelligence (AI) infrastructure.

Valued at US$17.4 billion over five years and expandable to US$19.4 billion if demand increases, the arrangement will see Nebius supply Microsoft with computing capacity from a new data center under construction in Vineland, New Jersey.

The news sent Nebius shares up 43.3 percent to US$91.75, their highest level on record.

Keep reading...Show less
OpenAI logo on a dark screen with a soft blue gradient background.

OpenAI Taps Broadcom to Build Custom AI Chips in Face of GPU Supply Concerns

OpenAI, the company behind ChatGPT, is reportedly set to begin large-scale production of its own artificial intelligence (AI) chips through a partnership with Broadcom (NASDAQ:AVGO).

Experts in the space see the move as a bid to cut reliance on chip giant NVIDIA (NASDAQ:NVDA) and ease the global shortage of processors driving platforms like ChatGPT.

The news came after Broadcom CEO Hock Tan told analysts in a September 4 call that the company had secured a fourth major customer that has committed to a US$10 billion order.

Keep reading...Show less
Person using laptop with generative AI, ChatGPT and other symbols floating between them.

10 Generative AI Stocks to Watch as ChatGPT Soars

The launch of OpenAI’s ChatGPT created a major buzz around artificial intelligence (AI) stocks.

ChatGPT is an AI chatbot software application that uses machine-learning techniques to emulate human-written conversations. This technology is called generative AI, and it's been making an impact on myriad industries, including marketing, security, healthcare, gaming, communication, customer service and software development.

The potential behind generative AI has been the primary driver behind a major stock rally that has helped the S&P 500 (INDEXSP:.INX) and Nasdaq Composite (INDEXNASDAQ:.IXIC) reach multiple new highs since 2023.

Keep reading...Show less
RemSense CEO and Managing Director Warren Cook

RemSense Eyes More Strategic Partnerships for Global Growth

RemSense (ASX:REM) is looking to secure more strategic partnerships as the company eyes global expansion, according to CEO and Managing Director Warren Cook.

“We have a strong pipeline of services to deliver to our existing clients that's going to take us right up through to the end of the year and into the early new year. For our global growth, we see partnerships as a critical part of our strategy to give us scale and capacity to grow throughout other parts of the region,” Cook said in an interview with the Investing News Network.

RemSense’s 3D visualisation technology — called virtualplant — is used by some major companies, including Woodside Energy Group (ASX:WDS,NYSE:WDS) and Chevron (NYSE:CVX).

Keep reading...Show less

Latest Press Releases

Related News